Close Menu

Over at The Personal Genome, Jason Bobe blogs about keeping biological data for non-clincial purposes separate from data for medical reasons, and lists some reasons. One, both physicians and regulators are already overburdened; two, restrictions on genetic testing presents problems regarding individual autonomy; and three, standardizing tests clinically puts an "unfair burden on individuals who may want to specifically avoid clinical implications of genetic sequence data."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.